Related Experiment Video

Updated: Apr 24, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

15.7K

Peutz-Jeghers syndrome--a rare case and a literature review

S Maslyankov, G Trifonov, D Kyoseva

    Khirurgiia
    |September 10, 2014
    PubMed

    Insights

    Peutz-Jeghers syndrome is an inherited disorder causing gastrointestinal polyps and skin spots. Early diagnosis and advanced screenings are crucial for preventing cancer development in affected individuals.

    Area of Science:

    • Genetics
    • Gastroenterology
    • Oncology

    Background:

    • Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant inherited disorder.
    • PJS is characterized by the development of hamartomatous polyps in the gastrointestinal tract.
    • Mucocutaneous melanin pigmentation is a hallmark clinical feature of PJS.

    Observation:

    • A case of Peutz-Jeghers syndrome with classic clinical manifestations was identified.
    • The diagnosis was established prior to the onset of any significant complications.
    • The patient presented with typical hamartomatous polyposis and mucocutaneous pigmentation.

    Findings:

    • The study highlights a successfully diagnosed case of Peutz-Jeghers syndrome.
    • Diagnosis was achieved through recognition of characteristic clinical features.
    • The case underscores the importance of timely identification of PJS.

    Implications:

    • Early diagnosis of Peutz-Jeghers syndrome is critical for patient management.
    • Aggressive surveillance protocols are recommended for individuals with PJS.
    • Advanced diagnostic and screening procedures can aid in preventing associated cancers.

    More Related Videos

    Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence06:23

    Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

    Published on: January 17, 2025

    1.2K
    Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

    Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

    Published on: November 26, 2018

    23.6K

    Related Concept Videos

    Barrett Esophagus-II: Clinical Manifestations and Management01:21

    Barrett Esophagus-II: Clinical Manifestations and Management

    Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
    To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
    1.7K
    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

    Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
    Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
    979
    Peptic Ulcer Disease II: Pathophysiology01:28

    Peptic Ulcer Disease II: Pathophysiology

    Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
    Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
    2.9K
    Peptic Ulcer Disease II: Pathophysiology01:24

    Peptic Ulcer Disease II: Pathophysiology

    Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
    36
    Barrett Esophagus-I: Introduction01:21

    Barrett Esophagus-I: Introduction

    Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
    This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
    1.5K
    Gastritis-II: Pathophysiology01:17

    Gastritis-II: Pathophysiology

    Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
    In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
    In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
    Gastritis can stem from various causes, each...
    1.9K